Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
0.458
+0.048 (11.77%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.

Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Allurion Technologies Inc.
Allurion Technologies logo
Country United States
Founded 2009
Industry Medical Devices
Sector Healthcare
Employees 504
CEO Shantanu Gaur

Contact Details

Address:
11 Huron Drive
Natick, Massachusetts 01760
United States
Phone 508 647 4000
Website allurion.com

Stock Details

Ticker Symbol ALUR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001964979
CUSIP Number 02008G102
ISIN Number US02008G1022
SIC Code 3841

Key Executives

Name Position
Dr. Samuel G. Levy Co-Founder
Dr. Ram Chuttani M.D. MD, Chief Medical Officer and Founding Partner
Ojas A. Buch Chief Operating Officer
Matt Wright Vice President of People
Joyce Johnson Senior Vice President of Regulatory Affairs and Quality Assurance

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 424B3 Prospectus
Nov 14, 2024 424B3 Prospectus
Nov 14, 2024 424B3 Prospectus
Nov 13, 2024 10-Q Quarterly Report
Nov 13, 2024 8-K Current Report
Nov 13, 2024 8-K Current Report
Nov 8, 2024 ARS Filing
Nov 8, 2024 DEF 14A Other definitive proxy statements